Pol Boudes

1.9k total citations
58 papers, 768 citations indexed

About

Pol Boudes is a scholar working on Physiology, Epidemiology and Rheumatology. According to data from OpenAlex, Pol Boudes has authored 58 papers receiving a total of 768 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Physiology, 20 papers in Epidemiology and 9 papers in Rheumatology. Recurrent topics in Pol Boudes's work include Lysosomal Storage Disorders Research (17 papers), Liver Disease Diagnosis and Treatment (9 papers) and Trypanosoma species research and implications (7 papers). Pol Boudes is often cited by papers focused on Lysosomal Storage Disorders Research (17 papers), Liver Disease Diagnosis and Treatment (9 papers) and Trypanosoma species research and implications (7 papers). Pol Boudes collaborates with scholars based in United States, France and United Kingdom. Pol Boudes's co-authors include David J. Lockhart, Kathy Nicholls, Dominique P. Germain, Sheela Sitaraman, Alexandra Steinberg, Charles A. McWherter, Roberto Giugliani, Robert L. Martin, Kenneth J. Valenzano and Franklin K. Johnson and has published in prestigious journals such as JAMA, Gastroenterology and PLoS ONE.

In The Last Decade

Pol Boudes

55 papers receiving 737 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pol Boudes United States 16 347 246 150 140 109 58 768
H Hartmann Germany 18 67 0.2× 569 2.3× 17 0.1× 167 1.2× 60 0.6× 71 1.1k
Didier Eyer France 10 98 0.3× 161 0.7× 30 0.2× 129 0.9× 29 0.3× 22 510
José Luis Aguilar United States 15 42 0.1× 160 0.7× 37 0.2× 140 1.0× 184 1.7× 46 1.0k
Ruy Pérez Tamayo Mexico 11 67 0.2× 366 1.5× 12 0.1× 127 0.9× 41 0.4× 37 891
Sreejith Parameswaran India 17 126 0.4× 99 0.4× 9 0.1× 233 1.7× 25 0.2× 111 1.0k
Silvia Esperanza Flores‐Martínez Mexico 16 137 0.4× 248 1.0× 15 0.1× 122 0.9× 55 0.5× 47 739
Patricia Nguyen Canada 8 17 0.0× 102 0.4× 63 0.4× 216 1.5× 234 2.1× 10 837
Martin L. Greene United States 17 53 0.2× 352 1.4× 19 0.1× 532 3.8× 114 1.0× 26 944
Micha Levi United States 15 72 0.2× 113 0.5× 16 0.1× 114 0.8× 87 0.8× 37 607
Marcelo Chen Taiwan 18 41 0.1× 164 0.7× 13 0.1× 238 1.7× 141 1.3× 95 1.1k

Countries citing papers authored by Pol Boudes

Since Specialization
Citations

This map shows the geographic impact of Pol Boudes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pol Boudes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pol Boudes more than expected).

Fields of papers citing papers by Pol Boudes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pol Boudes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pol Boudes. The network helps show where Pol Boudes may publish in the future.

Co-authorship network of co-authors of Pol Boudes

This figure shows the co-authorship network connecting the top 25 collaborators of Pol Boudes. A scholar is included among the top collaborators of Pol Boudes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pol Boudes. Pol Boudes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Noureddin, Mazen, Zachary Goodman, Dean Tai, et al.. (2023). Machine learning liver histology scores correlate with portal hypertension assessments in nonalcoholic steatohepatitis cirrhosis. Alimentary Pharmacology & Therapeutics. 57(4). 409–417. 13 indexed citations
2.
3.
Steinberg, Alexandra, Bradley Vince, Yun‐Jung Choi, et al.. (2016). The Pharmacodynamics, Pharmacokinetics, and Safety of Arhalofenate in Combination with Febuxostat When Treating Hyperuricemia Associated with Gout. The Journal of Rheumatology. 44(3). 374–379. 33 indexed citations
4.
Poiley, Jeffrey E., Alexandra Steinberg, Yun‐Jung Choi, et al.. (2016). A Randomized, Double‐Blind, Active‐ and Placebo‐Controlled Efficacy and Safety Study of Arhalofenate for Reducing Flare in Patients With Gout. Arthritis & Rheumatology. 68(8). 2027–2034. 61 indexed citations
5.
Choi, Yun Jung, Alexandra Steinberg, & Pol Boudes. (2015). AB0929 Elevation of Creatine Kinase in Gout Subjects. A Systematic Evaluation. Annals of the Rheumatic Diseases. 74. 1210–1211. 1 indexed citations
6.
7.
Boudes, Pol. (2013). Clinical studies in lysosomal storage diseases: past, present and future.. PubMed. 11 Suppl 1. 68–76. 3 indexed citations
8.
Boudes, Pol. (2013). Clinical studies in lysosomal storage diseases. PubMed. 1(1). e26690–e26690. 4 indexed citations
9.
Boudes, Pol. (2013). Gene therapy as a new treatment option for inherited monogenic diseases. European Journal of Internal Medicine. 25(1). 31–36. 21 indexed citations
10.
Nicholls, Kathy, Dominique P. Germain, Claudio Feliciani, et al.. (2013). Phase 3 study of migalastat HCl for Fabry disease: Stage 1 results. Molecular Genetics and Metabolism. 108(2). S70–S70. 4 indexed citations
11.
Germain, Dominique P., Roberto Giugliani, Derralynn Hughes, et al.. (2012). Safety and pharmacodynamic effects of a pharmacological chaperone on α-galactosidase A activity and globotriaosylceramide clearance in Fabry disease: report from two phase 2 clinical studies. Orphanet Journal of Rare Diseases. 7(1). 91–91. 77 indexed citations
12.
Wu, Xiaoyang, Evan Katz, Maria Cecilia Della Valle, et al.. (2011). A pharmacogenetic approach to identify mutant forms of α‐galactosidase a that respond to a pharmacological chaperone for Fabry disease. Human Mutation. 32(8). 965–977. 65 indexed citations
13.
Viereck, Christopher & Pol Boudes. (2011). An analysis of the impact of FDA's guidelines for addressing cardiovascular risk of drugs for type 2 diabetes on clinical development. Contemporary Clinical Trials. 32(3). 324–332. 14 indexed citations
14.
Viereck, Christopher & Pol Boudes. (2009). An analysis of current pharmaceutical industry practices for making clinical trial results publicly accessible. Contemporary Clinical Trials. 30(4). 293–299. 2 indexed citations
15.
Boudes, Pol. (2006). The challenges of new drugs benefits and risks analysis: Lessons from the ximelagatran FDA Cardiovascular Advisory Committee. Contemporary Clinical Trials. 27(5). 432–440. 35 indexed citations
16.
Xu, Ling, Jianli Liu, Jingfang Lin, et al.. (2003). Effects of bazedoxifene (TSE-424), a novel tissue selective estrogen receptor modulator (SERM), on biochemical markers of bone metabolism in a chinese population. Open Repository and Bibliography (University of Liège). 1 indexed citations
17.
Boudes, Pol. (1998). Drug Compliance in Therapeutic Trials. Controlled Clinical Trials. 19(3). 257–268. 55 indexed citations
18.
Boudes, Pol. (1991). HIV infection in the elderly.. PubMed. 17(9). 39–42. 7 indexed citations
19.
Gény, Christian, Romain K. Gherardi, Pol Boudes, et al.. (1991). Multifocal multinucleated giant cell myelitis in an AIDS patient. Neuropathology and Applied Neurobiology. 17(2). 157–162. 21 indexed citations
20.
Boudes, Pol. (1990). Mediastinal tumour as the presenting manifestation of Wegener's granulomatosis. Journal of Internal Medicine. 227(3). 215–217. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by H Hartmann Breakdown of academic impact, for papers by Didier Eyer Breakdown of academic impact, for papers by José Luis Aguilar Breakdown of academic impact, for papers by Ruy Pérez Tamayo Breakdown of academic impact, for papers by Sreejith Parameswaran Breakdown of academic impact, for papers by Silvia Esperanza Flores‐Martínez Breakdown of academic impact, for papers by Patricia Nguyen Breakdown of academic impact, for papers by Martin L. Greene Breakdown of academic impact, for papers by Micha Levi Breakdown of academic impact, for papers by Marcelo Chen
Rankless by CCL
2026